<DOC>
	<DOCNO>NCT01988831</DOCNO>
	<brief_summary>Melanoma 's incidence increase worldwide . The effort make melanoma screening lead early detection primary tumour good prognosis , melanoma remain aggressive cancer come metastatic stage . Three recent retrospective study compare group patient diagnose primary melanoma treat betablockers another indication patient never receive betablockers . In three study , outcome disease significantly well people betablocker treatment decrease rate recurrence well 5 year survival rate . Here want investigate efficacy tolerability adjuvant treatment propranolol patient suffer primary melanoma high risk recurrence .</brief_summary>
	<brief_title>Efficacy Propranolol Treatment Prevent Melanoma Progression</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>patient 18 y.o Breslow index &gt; 1mm Breslow index ulcerate primary lesion Melanoma stage AJCC Ib , IIa , IIb , IIc , IIIa , IIIb IIIc Able undergo outpatient treatment No contra indication betablockers define compendium No clinical evidence coagulopathy No unstable angina pectoris No AVblock II III without pacemaker No severe congestive heart failure No untreated phaeochromocytoma No severe bradycardia No severe hypotension No severe impairment peripheral arterial circulation No uncontrolled cardiac arrhythmia No severe asthma COPD No uncontrolled diabetes mellitus No Angioneurotic edema No severe Aortic valve stenosis No severe hypertrophic cardiomyopathy No severe renal dysfunction No patient beta blocker inclusion No known adverse reaction betablockers No pregnant lactating patient include No melanoma stage AJCC IV inclusion No patient require specific oncological treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Malignant melanoma</keyword>
	<keyword>betablocker</keyword>
	<keyword>propranolol</keyword>
	<keyword>interventional</keyword>
	<keyword>prospective</keyword>
	<keyword>adjuvant</keyword>
	<keyword>recurrence</keyword>
</DOC>